JP2025508331A5 - - Google Patents
Info
- Publication number
- JP2025508331A5 JP2025508331A5 JP2024544646A JP2024544646A JP2025508331A5 JP 2025508331 A5 JP2025508331 A5 JP 2025508331A5 JP 2024544646 A JP2024544646 A JP 2024544646A JP 2024544646 A JP2024544646 A JP 2024544646A JP 2025508331 A5 JP2025508331 A5 JP 2025508331A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- heteroalkyl
- alkenyl
- heteroalkenyl
- heteroalkynyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210107273.0 | 2022-01-28 | ||
| CN202210107273 | 2022-01-28 | ||
| PCT/IB2023/050766 WO2023144782A1 (zh) | 2022-01-28 | 2023-01-30 | 抗血小板药物的药物组合物及其用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025508331A JP2025508331A (ja) | 2025-03-26 |
| JP2025508331A5 true JP2025508331A5 (enExample) | 2026-02-20 |
Family
ID=87470993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024544646A Pending JP2025508331A (ja) | 2022-01-28 | 2023-01-30 | 抗血小板薬の医薬組成物およびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20250152571A1 (enExample) |
| EP (1) | EP4470539A4 (enExample) |
| JP (1) | JP2025508331A (enExample) |
| KR (1) | KR20240142492A (enExample) |
| CN (1) | CN118613262A (enExample) |
| AU (1) | AU2023211946A1 (enExample) |
| CA (1) | CA3248916A1 (enExample) |
| IL (1) | IL314332A (enExample) |
| TW (1) | TW202339745A (enExample) |
| WO (1) | WO2023144782A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025108300A1 (zh) * | 2023-11-24 | 2025-05-30 | 上海柯君医药科技有限公司 | 一种含哌啶环化合物的苯磺酸盐的晶型、其制备方法及应用 |
| WO2025108307A1 (zh) * | 2023-11-24 | 2025-05-30 | 上海柯君医药科技有限公司 | 一种含哌啶环化合物的苯磺酸盐、其制备方法及应用 |
| CN119019320B (zh) * | 2024-10-29 | 2025-03-11 | 上海柯君医药科技有限公司 | 一种具有抗血小板活性的哌啶类化合物的制备方法 |
| CN119192061B (zh) * | 2024-11-28 | 2025-05-13 | 上海柯君医药科技有限公司 | 一种含哌啶环的化合物的纯化方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740686B1 (fr) | 1995-11-03 | 1998-01-16 | Sanofi Sa | Formulation pharmaceutique lyophilisee stable |
| FR2782455B3 (fr) | 1998-08-20 | 2000-09-15 | Sanofi Sa | Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine |
| JP5681485B2 (ja) * | 2007-04-27 | 2015-03-11 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | クロピドグレルおよびスルホアルキルエーテルシクロデキストリンを含有する製剤ならびに使用方法 |
| CN101579337A (zh) * | 2009-02-25 | 2009-11-18 | 牛华英 | 氯吡格雷组合物及其制备方法 |
| CA2761455C (en) * | 2009-05-13 | 2018-06-12 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| WO2014118649A2 (en) * | 2013-01-19 | 2014-08-07 | Mahesh Kandula | Compositions and methods for the treatment of cardiovascular diseases |
| CN106554303A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN106554368A (zh) * | 2015-09-25 | 2017-04-05 | 陕西合成药业股份有限公司 | 噻吩并吡啶类衍生物及其制备方法和用途 |
| CN111848497A (zh) * | 2020-07-28 | 2020-10-30 | 内蒙古医科大学 | 氯吡格雷活性代谢物衍生物、其前药及其制备方法与应用 |
| AU2021317436A1 (en) * | 2020-07-29 | 2023-02-23 | Shanghai Curegene Pharmaceutical Co., Ltd. | Antiplatelet drugs and uses thereof |
-
2023
- 2023-01-16 TW TW112101736A patent/TW202339745A/zh unknown
- 2023-01-30 CA CA3248916A patent/CA3248916A1/en active Pending
- 2023-01-30 CN CN202380018894.4A patent/CN118613262A/zh active Pending
- 2023-01-30 JP JP2024544646A patent/JP2025508331A/ja active Pending
- 2023-01-30 AU AU2023211946A patent/AU2023211946A1/en active Pending
- 2023-01-30 WO PCT/IB2023/050766 patent/WO2023144782A1/zh not_active Ceased
- 2023-01-30 US US18/832,936 patent/US20250152571A1/en active Pending
- 2023-01-30 EP EP23746577.8A patent/EP4470539A4/en active Pending
- 2023-01-30 IL IL314332A patent/IL314332A/en unknown
- 2023-01-30 KR KR1020247028639A patent/KR20240142492A/ko active Pending
-
2025
- 2025-06-20 US US19/243,756 patent/US20250312326A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025508331A5 (enExample) | ||
| CA2556872C (en) | Modulation of inflammatory and metastatic processes | |
| JP2021063119A (ja) | 噴霧乾燥製剤 | |
| JP2020535218A (ja) | ＳＨＰ２のオクタヒドロシクロペンタ［ｃ］ピロールのアロステリック阻害剤 | |
| JP2023529354A5 (enExample) | ||
| JP6100700B2 (ja) | 組合せ | |
| JP2010528026A5 (enExample) | ||
| CN110603252A (zh) | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 | |
| TWI439464B (zh) | 二胺衍生物之製造方法 | |
| CA2419633C (en) | Substituted imidazoles as tafia inhibitors | |
| JP2009504764A5 (enExample) | ||
| CN105120866A (zh) | 与毒性醛相关的疾病和治疗 | |
| JP2023535815A5 (enExample) | ||
| JP2014512364A5 (enExample) | ||
| JP6882538B2 (ja) | 注射用組成物 | |
| RU2007101653A (ru) | Производные 1-азабицикло[3.3.1]нонанов | |
| CN113768870B (zh) | 含青蒿琥酯的组合物及其应用 | |
| WO2016154524A1 (en) | Carbonic anhydrase inhibitors and uses related thereto | |
| WO2018043530A1 (ja) | 抗腫瘍剤、抗腫瘍効果増強剤及び抗腫瘍用キット | |
| JP2023549187A5 (enExample) | ||
| CN115835888A (zh) | 酰胺官能团中的稳定重同位素及其用途 | |
| EP3454852A1 (en) | Phosphotidylinositol 3-kinase inhibitors | |
| AU2016263311A1 (en) | Novel amidoheteroaryl aroyl hydrazide ethynes | |
| TWI817065B (zh) | 改善透明質酸-藥物複合物之接枝率及/或接枝效率的方法 | |
| KR102222774B1 (ko) | 에독사반을 포함하는 약학적 제제 및 이의 제조방법 |